Beta-adrenoceptor agonists and asthma--100 years of development.
about
Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary diseaseA cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging.Three-dimensional pharmacology, a subject ranging from ignorance to overstatements.Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonistsAnalysis of multiple compound-protein interactions reveals novel bioactive moleculesDesensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.An optical multi-sensing system for detection of cardiovascular toxicity.Development of a Efficient and Sensitive Dispersive Liquid-Liquid Microextraction Technique for Extraction and Preconcentration of 10 β2-Agonists in Animal Urine.Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor-mediated responses in human lung mast cells.G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Doxofylline and Terbutalinesulphate in Pharmaceutical Formulations.The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD.Asthma: a simple concept but in reality a complex disease.Third-generation long-acting β₂-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β₂-adrenoceptor agonists.Epithelial function and dysfunction in asthma.Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation.Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.β2 AgonistsBronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.Identification and Functional Characterization of Cis-Regulatory Elements Controlling Expression of the Porcine ADRB2 Gene.Overview of the Anatomy, Physiology, and Pharmacology of the Autonomic Nervous System.Step 4: stick or twist? A review of asthma therapy.Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint.Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma modelMolecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor.Evidence showing that beta-adrenoceptor subtype responsible for the relaxation induced by isoprenaline is principally beta 2 but not beta 1 in guinea-pig tracheal smooth muscle.Comparative pharmacokinetics and bile transformation of R-enantiomer and racemic bambuterol after single-dose intravenous, oral administration in rats and beagle dogs.Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle.Resolution of Rac-Bambuterol via Diastereoisomeric Salt Formation with o-Chloromandelic Acid and Differences in the Enantiomers' Pharmacodynamical Effects in Guinea Pigs and Beagles.Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat.Sympathetic-induced changes in discharge rate and spike-triggered average twitch torque of low-threshold motor units in humans.Step 4: stick or twist? A review of asthma therapy.Use and safety of long-acting β2-agonists for pediatric asthmaValidated HPLC Method for Separation and Determination of Terbutaline Enantiomers
P2860
Q28261960-6B67112B-1F27-462E-A6B2-B72C0BC8B45CQ30538150-01B821EC-7A0F-40DA-8F52-A59FD0934FECQ31027709-3075F1E7-25BE-47F3-9097-FA1B96AD92ADQ34332971-3B97A21C-60FD-4125-9ECA-86343E3E3CD7Q34979708-5487A4C7-9C19-40D9-A6DC-1A62C2DACD51Q35046032-D6135C9A-D707-4919-A97A-A6EC83348D5BQ35047601-EC2B4767-2494-453B-8635-D92460120791Q35101016-C7A4D54D-CD1E-458D-9CB5-4248F244E1A7Q35766904-6B57BD6A-0842-4E4B-BCFE-FB0AC9255821Q36094361-911851E0-22C8-467F-9B1D-472D96DC60E0Q36168847-0BDFB520-F575-4A49-8B3C-580549591D7AQ37401706-298BF006-47B3-4366-8AE3-2E228EB2A0DFQ37481301-4EF7FB32-BCF3-4812-8165-43B43B43FDDAQ37846698-51D39D24-2646-4A91-B244-E926C4DCCA40Q37880256-7C45FC85-ED43-4C75-B00B-01C45BB5C569Q37937552-AE232B22-9D4A-4E91-9C0E-939D0AD2EB29Q38198788-6C169408-6890-43D0-9243-C4084D8621F0Q38234940-248E92F0-17EA-4347-BA04-6E0D9881F474Q38248438-097A3BC9-4AEA-47CE-AB28-D71F6CC6F35AQ38791742-0145C64F-85B0-4F9B-AB72-4131DF397405Q38817408-86F1BC32-D52F-477A-BDE4-EE1BCDC370FDQ38848359-BE5D4368-8376-41E7-85EF-257EA079E57EQ38878230-C2C7DE2B-028B-44C5-8445-60DEF004D57BQ38960423-3CD86897-4D8C-479E-BF1F-81D6423CE4A2Q41587356-B51848E1-ADF5-49A1-9C97-E66FDD590D54Q41928013-568DB6A8-E7A6-4572-80EC-D38F1B028AFBQ43849764-68366B47-F014-4B56-AC45-1A73F01778BFQ45085952-3ED87D8B-0B5E-4D59-BFB0-C41088C81AB1Q46830391-E7BE8CF5-F4CA-4980-8510-040E2F5E856BQ46842644-197926E4-A64A-4E42-B61B-20EEBCD96DF7Q46919229-F6957D98-F7AC-4637-9731-8DB733096187Q47348707-1A7C414D-D711-445C-BA6D-E8FE3734C944Q51744835-2B963C01-00E6-402D-B1E2-AEA271328999Q53451569-9361696B-E60B-4433-B405-ADF31DD6ED92Q54887789-427D7B36-528C-49D8-94A8-E4A92DE3BDF4Q57821604-CD3D851D-483F-4814-82D6-EB58E9ECD885Q58187114-A1AF1DCD-7C14-47F0-9C7E-EE12FCE6C956
P2860
Beta-adrenoceptor agonists and asthma--100 years of development.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Beta-adrenoceptor agonists and asthma--100 years of development.
@ast
Beta-adrenoceptor agonists and asthma--100 years of development.
@en
Beta-adrenoceptor agonists and asthma--100 years of development.
@nl
type
label
Beta-adrenoceptor agonists and asthma--100 years of development.
@ast
Beta-adrenoceptor agonists and asthma--100 years of development.
@en
Beta-adrenoceptor agonists and asthma--100 years of development.
@nl
prefLabel
Beta-adrenoceptor agonists and asthma--100 years of development.
@ast
Beta-adrenoceptor agonists and asthma--100 years of development.
@en
Beta-adrenoceptor agonists and asthma--100 years of development.
@nl
P1476
Beta-adrenoceptor agonists and asthma--100 years of development.
@en
P2093
Bertil Waldeck
P356
10.1016/S0014-2999(02)01728-4
P407
P577
2002-06-01T00:00:00Z